ArticleEBioMedicine2022

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.

Anupriya Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.